Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BREC: Customized Chemotherapy in Advanced NSCLC
NCT00617656Phase 3Terminated
- Sponsor
- Fundación GECP
- Start
- Feb 2008
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, cisplatin, docetaxel in non-small cell lung cancer (NSCLC), sponsored by Fundación GECP. Started Feb 2008; status: terminated.
02
Drugs
gemcitabinecisplatindocetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00617656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00617656.